SB 1673, the "Prosthetic Access and Accountability Act of 2026," requires health benefit plans in Oklahoma to cover physician-prescribed prosthetic and orthotic devices (like artificial limbs or braces) needed to restore physical function. It prohibits denials based on disability, cost, or device classification, mandates health plans to review urgent requests within 2 business days (and standard requests within 10), and automatically approves requests if deadlines are missed. Health plans must reimburse out-of-network providers for covered devices if in-network options are unavailable due to location, and they face liability for harm caused by denied or delayed coverage - including medical costs, lost wages, and punitive damages in cases of bad faith. The Oklahoma Insurance Commissioner will enforce these rules, investigate complaints, and publish annual reports on coverage denials and patient outcomes.
SB 392 extends the expiration date of Oklahoma's Long-Term Care Facility Advisory Council from July 1, 2025, to July 1, 2026. The council, which advises on standards for nursing homes, residential care facilities, and adult day care services, continues with its existing structure of 13 members including healthcare professionals and public representatives over age 65. This extension ensures uninterrupted review of care quality, facility regulations, and enforcement under the Nursing Home Care, Residential Care, and Adult Day Care Acts. The bill does not alter the council's duties or membership requirements.
The provided context does not include the bill text or specific provisions of SB 1047. Without details on which health care services require reimbursement, the reimbursement mechanisms, or the affected entities (e.g., insurers, providers, patients), a factual summary cannot be created. The bill's title mentions "reimbursement for certain health care services" but lacks concrete policy details in the available information. For an accurate summary, the full bill text or a detailed legislative summary would be required.
SB 1646 requires Oklahoma health insurance plans to cover medically necessary mental health and substance use disorder treatment without arbitrary limits, affecting all residents with such coverage. It mandates coverage for "core treatments" aligned with clinical standards (like those from psychiatric associations), prohibits limiting care to short-term/acute settings, and bans insurers from rescinding authorizations after services are provided. The bill also requires insurers to follow specific rules for reviewing treatment requests and ensures out-of-network care access when in-network options aren't available. This applies to all health benefit plans covering hospital or medical services in Oklahoma, aiming to align mental health coverage with physical health benefits. The bill is pending in committee as of February 2026.
SB 202 modifies eligibility rules for self-funded health plans to participate in Oklahoma's Medicaid premium assistance program. It allows small businesses and public entities using self-funded health plans to qualify if the plan was already used by an employer in the program as of May 1, 2024, or if it’s owned by a local government public trust. This change specifically affects small employers (under 250 employees) and public-sector health plans seeking to access state premium assistance. The bill aims to expand coverage options for low-income workers by making more health plan types eligible for state-funded premium support.
This bill authorizes an emergency appropriation of approximately $19.66 million to the Oklahoma Department of Mental Health and Substance Abuse Services. The funds must come from the Rate Preservation Fund in the State Treasury and are designated specifically for Title XIX services, which are Medicaid-funded mental health and substance abuse programs. The legislation includes an emergency provision, allowing the funding to take effect immediately upon the governor's approval without waiting for the regular budget cycle. This action provides direct financial resources to the state agency responsible for administering mental health and substance abuse services.
HB 1484, known as "Rain's Law," requires Oklahoma public schools to provide annual, research-based instruction on fentanyl abuse prevention and drug poisoning awareness to students in grades 6 through 12. The bill mandates that this instruction cover suicide prevention, fentanyl abuse and addiction prevention, local resource access, and health education about fentanyl use. Schools must incorporate this content into health classes, and the State Department of Education will develop curriculum standards and resources to support implementation. The law also designates a week for "Fentanyl Poisoning Awareness Week" to align with National Red Ribbon Week, with age-appropriate instruction determined by each school district.
SB 1953, the Employer Health Plan Transparency Act, requires group health plans and public employee health plans in Oklahoma to ensure contracts with health insurers and service providers include full access to medical records, billing details, and payment documentation. It prohibits contracts from limiting information sharing about patient care or costs, mandates HIPAA-compliant disclosures, and requires itemized cost breakdowns for covered services. This directly affects employers offering health benefits, insurers, and healthcare providers by standardizing data access and transparency in coverage arrangements. The law aims to improve clarity for plan participants regarding medical expenses and service coverage under Oklahoma's health insurance framework.
SB 207 establishes the Oklahoma Rare Disease Advisory Council within the State Department of Health to address the needs of Oklahomans living with rare diseases (defined as conditions affecting fewer than 200,000 people nationally). The Council, composed of 13 diverse members including patients, caregivers, healthcare providers, researchers, and industry representatives, will conduct public hearings, develop policy recommendations, and create emergency care protocols to improve access to specialists, diagnostics, and equitable treatment. The bill also modifies Oklahoma’s newborn screening program to require an educational initiative for treatable genetic disorders, aiming to prevent intellectual disabilities and reduce infant mortality through early intervention. This legislation directly affects rare disease patients, their families, healthcare providers, and state agencies responsible for public health programs in Oklahoma.
SB 1039 modifies Oklahoma's medical marijuana licensing system. It establishes a new Oklahoma Medical Marijuana Authority to process applications, sets a $100 biannual fee (or $20 for Medicaid/Medicare/SoonerCare users) for patient licenses, and creates three license types: standard two-year licenses, 60-day short-term licenses for patients with limited physician recommendations, and 30-day temporary licenses for out-of-state patients from regulated states. The bill requires the Authority to review applications within 14 business days and provide written denial reasons, while also creating caregiver licenses for homebound patients with specific limits. This law directly affects Oklahoma residents seeking medical marijuana access, out-of-state visitors with valid programs, and caregivers.
